Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPSTER study of perioperative dexamethasone after total hip arthroplasty
2025-524368-39-00Phase 4Authorised
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexamethasone in N/A, sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Health-related quality of life at day 90. Planned start Jan 2026; status: authorised.
02
Drugs
dexamethasone
03
Conditions
N/A
Beyond the preview
Go deeper on 2025-524368-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524368-39-00.